Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy

2013129 citationsJournal Articlegreen Open Access

Authors

Chris Recknor · Amgen (United States)

E. J. Czerwiński

Abstract

In postmenopausal women previously treated with a bisphosphonate and low BMD, denosumab treatment resulted in greater BMD increases than ibandronate at all measured sites. No new safety risks with denosumab treatment were identified.

Topics & Keywords

Bone health and treatments Bone health and osteoporosis research Bone and Joint Diseases

Publication Details

Published in: Obstetrics and Gynecology

Volume 121, Issue 6, pp. 1291-1299

DOI: 10.1097/aog.0b013e318291718c

Field-Weighted Citation Impact: 6.10

Command Palette

Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy

Authors

Abstract

Topics & Keywords

Publication Details